Patient | Age of MI (years) | Duration of MI (months) | Heart failure | Elevated CTni | Elevated NT-proBNP | ECG | Echo | CMR |
---|---|---|---|---|---|---|---|---|
1 | 14 | 2 | Y | Y | Y | Ventricular arrhythmia | Cardiomyopathy | LGE + |
2 | 21 | 2 | Y | Y | Y | - | LVEF < 50% | LGE + |
3 | 29 | 27 | Y | Y | Y | Atrioventricular block | Wall motion abnormality LVEF < 50% | LGE + Ventricular hypertrophy |
4 | 34 | 34 | Y | Y | Y | - | LVEF < 50% | NA |
5 | 34 | 124 | N | Y | Y | Ventricular arrhythmia | Cardiomyopathy Ventricular hypertrophy | Ventricular hypertrophy |
6 | 35 | 80 | Y | Y | Y | Ventricular hypertrophy | Cardiomyopathy LVEF < 50% | NA |
7 | 35 | 7 | Y | Y | Y | - | Wall motion abnormality LVEF < 50% | NA |
8 | 37 | 28 | N | Y | N | - | Ventricular hypertrophy | NA |
9 | 38 | 37 | Y | N | Y | Supraventricular arrhythmia | Wall motion abnormality | LGE + |
10 | 45 | 0 | Y | N | Y | - | Cardiomyopathy LVEF < 50% | LGE + |
11 | 44 | 12 | Y | Y | Y | Atrioventricular block | Cardiomyopathy LVEF < 50% | Wall motion abnormality |
12 | 52 | 61 | N | N | N | Ventricular arrhythmia | - | LGE + |
13 | 51 | 2 | N | N | N | - | - | LGE + Ventricular hypertrophy |
14 | 55 | 13 | N | NA | Y | - | Cardiomyopathy Ventricular hypertrophy LVEF < 50% | NA |
15 | 55 | 108 | N | Y | N | - | - | LGE + Ventricular hypertrophy |
16 | 60 | 130 | Y | Y | Y | Ventricular arrhythmia | - | LGE + |
17 | 60 | 5 | Y | Y | Y | Atrioventricular block | LVEF < 50% | NA |
18 | 62 | 205 | N | N | Y | - | Wall motion abnormality | LGE + Ventricular hypertrophy |
19 | 64 | 2 | N | Y | Y | - | Ventricular enlargement | Ventricular enlargement |
20 | 68 | 55 | N | NA | Y | - | LVEF < 50% | LGE + Ventricular hypertrophy |
21 | 69 | 20 | N | Y | Y | Atrial fibrillation | - | LGE + Ventricular hypertrophy |